CD79A and COVID-19: This was supported by the report by Pace et al., which confirmed neutralising capacity for anti-SARS-CoV-2-specfic IgA and IgG in human milk, suggesting milk-derived immunoglobulins could be a possible therapeutic intervention for COVID-19 [18].